We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

BIO-RAD LABORATORIES

Provides full range of instrumentation, reagent kits, software and quality control systems to clinical laboratories. ... read more Featured Products: More products

Download Mobile App





Bio-Rad Showcases Comprehensive Range of Quality Control-Related Offerings

By LabMedica International staff writers
Posted on 20 Jul 2023
Print article
Image: The Cardiac Advance Control contains the ten most tested cardiac analytes (Photo courtesy of Bio-Rad)
Image: The Cardiac Advance Control contains the ten most tested cardiac analytes (Photo courtesy of Bio-Rad)

Bio-Rad Laboratories (Hercules, CA, USA) is showcasing its comprehensive range of quality control-related offerings at the American Association of Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo, AACC 2023, in Anaheim, Calif., July 23-27. At booth #3239 on the AACC 2023 exhibition floor, attendees can explore and learn about Bio-Rad’s leading QC products, including the new Cardiac Advance product, Exact Diagnostics branded infectious disease molecular quality controls & panels, the family of InteliQ Load-and-Go controls, and Unity Next Peer QC data management solutions.

At the Bio-Rad AACC booth, visitors can explore its new comprehensive, multi-analyte control optimized for high sensitivity Troponin testing. Containing the ten most tested cardiac analytes, Cardiac Advance Control offers a consolidated formula to monitor the precision of cardiac laboratory testing procedures in one comprehensive control. Additionally, Bio-Rad’s InteliQ Load-and-Go controls allow labs to transform their QC workflow with load-and-go efficiency. InteliQ quality controls empower labs by automating workflow - reducing turnaround time, limiting manual errors, and increasing overall efficiency. Visitors to the company’s booth can also learn more about its latest offering, Unity Next Peer QC, which is a simple peer comparison tool with instant access to peer reporting in a centralized, user-friendly platform. Built on the foundation of Unity and supported by comprehensive QC data, Unity Next helps labs confidently make decisions to mitigate QC errors and protect patient safety.

At AACC 2023, Bio-Rad is also demonstrating how to streamline diabetes testing with fast and accurate smart HPLC and perform A1c testing without common hemoglobin variant interference. The company is demonstrating the D-100 hemoglobin testing system, a fully automated, best-in-class HbA1c analyzer for high-volume labs. The D-100 delivers more results with less effort with SMART HPLC, without sacrificing quality or workflow efficiency. In addition, Bio-Rad is demonstrating the BioPlex 2200 System, a fully automated, random-access, track line compatible, multiplex platform. BioPlex 2200 improves turnaround time, throughput, and overall workflow efficiency. With over 50 multiplex assays, the BioPlex System consolidates autoimmune, infectious disease, and vitamin D testing. One of the highlighted events during the conference is Bio-Rad’s industry workshop titled “A New Era in Laboratory Quality – Managing Molecular QC Data.” The workshop aims to provide attendees with valuable insights, including a discussion on molecular QC data management workflow improvements post-Unity implementation, a description of the value of Unity in evaluating the performance of viral load assays, and an identification of three essential functions of Unity for QC data management.

Related Links:
Bio-Rad Laboratories

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: Molecular PCR-grade detection of Lyme bacteria right at the tick bite (Photo courtesy of En Carta Diagnostics)

Groundbreaking Molecular Diagnostic Kit to Provide Lyme Disease Detection in Minutes

Lyme disease, transmitted through tick bites, is a bacteria-caused illness that impacts 1.2 million individuals annually. The standard methods for diagnosing this disease include clinical examinations,... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

Multiple sclerosis (MS) is a chronic neurological condition for which there is currently no cure. It affects around three million people globally and ranks as the second most common cause of disability... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: Insulin proteins clumping together (Photo courtesy of Jacob Kæstel-Hansen)

AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.